title: Vildagliptin was noninferior to rosiglitazone for glycemic control in type 2 diabetes but caused less weight gain.
authors.affiliation: Knowledge and Encounter Research Unit, Mayo Clinic, Rochester, Minnesota, USA.
authors.forename: Victor M
authors.initials: VM
authors.lastname: Montori